[HTML][HTML] Cancer driver gene and non-coding RNA alterations as biomarkers of brain metastasis in lung cancer: a review of the literature
Brain metastasis (BM) is the most common event in patients with lung cancer. Despite
multimodal treatments and advances in systemic therapies, development of BM remains one …
multimodal treatments and advances in systemic therapies, development of BM remains one …
[HTML][HTML] The role of noncoding RNAs in the regulation of anoikis and anchorage-independent growth in cancer
HY Lee, SW Son, S Moeng, SY Choi… - International journal of …, 2021 - mdpi.com
Cancer is a global health concern, and the prognosis of patients with cancer is associated
with metastasis. Multistep processes are involved in cancer metastasis. Accumulating …
with metastasis. Multistep processes are involved in cancer metastasis. Accumulating …
[HTML][HTML] Multifaceted roles of caveolin-1 in lung cancer: a new investigation focused on tumor occurrence, development and therapy
Lung cancer is one of the most common and malignant cancers with extremely high
morbidity and mortality in both males and females. Although traditional lung cancer …
morbidity and mortality in both males and females. Although traditional lung cancer …
EWI‐2 controls nucleocytoplasmic shuttling of EGFR signaling molecules and miRNA sorting in exosomes to inhibit prostate cancer cell metastasis
C Fu, Q Zhang, A Wang, S Yang, Y Jiang… - Molecular …, 2021 - Wiley Online Library
Early and accurate diagnosis of prostate cancer (PCa) is extremely important, as metastatic
PCa remains hard to treat. EWI‐2, a member of the Ig protein subfamily, is known to inhibit …
PCa remains hard to treat. EWI‐2, a member of the Ig protein subfamily, is known to inhibit …
Role of caveolin-1 in human organ function and disease: friend or foe?
L Pang, S Yang, W Dai, S Wu, J Kong - Carcinogenesis, 2022 - academic.oup.com
Abstract Caveolin-1 (Cav-1) is a structural protein component of caveolae, which are
invaginations of the plasma membrane involved in various cellular processes, including …
invaginations of the plasma membrane involved in various cellular processes, including …
[HTML][HTML] Clinical significance of high expression of proliferating cell nuclear antigen in non-small cell lung cancer
X Ye, B Ling, H Xu, G Li, X Zhao, J Xu, J Liu, L Liu - Medicine, 2020 - journals.lww.com
Although proliferating cell nuclear antigen (PCNA) plays an important role in tumor
proliferation and its expression level is closely related to the biological activity of tumor cells …
proliferation and its expression level is closely related to the biological activity of tumor cells …
[HTML][HTML] Ketogenic diet inhibits tumor growth by enhancing immune response, attenuating immunosuppression, inhibiting angiogenesis and EMT in CT26 colon tumor …
W Sun, J Yang, B Liu, Q Liu, T Wang, Q Wang… - Journal of Functional …, 2022 - Elsevier
Ketogenic diet (KD) has increasingly captured the attention of researchers due to its anti-
tumor activity. Here, we found that KD treatment significantly enhanced tumor-reactive …
tumor activity. Here, we found that KD treatment significantly enhanced tumor-reactive …
[HTML][HTML] Sanguisorba officinalis L. Suppresses Triple-Negative Breast Cancer Metastasis by Inhibiting Late-Phase Autophagy via Hif-1α/Caveolin-1 Signaling
N Wang, G Muhetaer, X Zhang, B Yang… - Frontiers in …, 2020 - frontiersin.org
Sanguisorba officinalis L.(SA) is a common herb for cancer treatment in the clinic,
particularly during the consolidation phase to prevent occurrence or metastasis …
particularly during the consolidation phase to prevent occurrence or metastasis …
[HTML][HTML] A novel protein-drug conjugate, SSH20, demonstrates significant efficacy in caveolin-1-expressing tumors
In recent years, human serum albumin (HSA) has been characterized as an ideal drug
carrier in the cancer arena. Caveolin-1 (Cav-1) has been established as the principal …
carrier in the cancer arena. Caveolin-1 (Cav-1) has been established as the principal …
[HTML][HTML] Targeting DNAJC19 overcomes tumor growth and lung metastasis in NSCLC by regulating PI3K/AKT signaling
J Zhou, Y Peng, Y Gao, T Chen, P Li, K Xu, T Liu… - Cancer Cell …, 2021 - Springer
Background Some driver oncogenes are still unknown in non-small-cell lung cancer
(NSCLC). DNAJC19, a major component of the translocation machinery of mitochondrial …
(NSCLC). DNAJC19, a major component of the translocation machinery of mitochondrial …